New search | Conferencedetail
Print view
 
 

Gene Therapy for Rare Disorders Summit

evvnt Platform / evvnt
Conference themes
Gene Therapy for Rare Disorders 2018 will equip you with the insights to make the most of this unprecedented opportunity. Rather than attempting to cover the entire cell and gene therapy world, this meeting will focus specifically on the critical clinical, manufacturing, regulatory and reimbursement challenges involved in delivering gene therapies to market.
Professional congress organizer (PCO)
Hanson Wade
Notes
Katherine High (Spark Therapeutics), Philip Gregory (Bluebird Bio), Steven Paul (Voyager Therapeutics), Jude Samulski (Pfizer), Steven Zelenkofske (uniQure), Mary Dunkle (NORD), Sven Kili (GSK), Olivier Danos (REGENXBIO), and Gumei Liu (FDA)
 

Enquiries and Registration:

https://go.evvnt.com/178854-2?pid=4832
Mr. Customer Services
 
Categories
General Medicine
Languages
English
Congress fees
USD 3.997,00
(Conference + 2 Workshops: USD 3997, Conference + 1 Workshop: USD 3398, Conference Only: USD 2799, Workshop Only: USD 699, Focus Evenin: USD 0.)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Charité International AcademyCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Health Forum GasteinÖsterreichische Gesellschaft für Public HealthAMREF - African Medical and Research FoundationÖsterreichisches Rotes KreuzEuropean Public Health Association (EUPHA)Swiss Tropical and Public Health Institute

Facebook

Give us your professional opinion

Start survey

Start survey